Nanotechnology Now - News Story: Arrowhead Completes Warrant Redemption

Home > News > Arrowhead Completes Warrant Redemption

June 16th, 2005

Arrowhead Completes Warrant Redemption

Abstract:
The net proceeds of over $20 million in cash will be used to fund the Company's subsidiaries, the Company's research projects and general working capital purposes.

Source:
businesswire

Bookmark:

Related Links

Arrowhead Research Corporation

Related News Press

Announcements

A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect April 17th, 2026

Qjump: Shallow-circuit quantum sampling guides combinatorial optimization On up to 104 superconducting qubits, Qjump assists in searching the ground states of hard Ising problems and might outperform simulated annealing on near-term quantum hardware April 17th, 2026

Rice study resolves decades-old mystery in organic light-emitting crystals: Findings reveal how molecular defects can enhance light conversion efficiency: April 17th, 2026

UC Irvine physicists discover method to reverse ‘quantum scrambling’ : The work addresses the problem of information loss in quantum computing system April 17th, 2026

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021



Premium Products


	Only the news you want to read! Learn More



	Full-service, expert consulting Learn More




	The latest news from around the world, FREE